Agios Pharmaceuticals
AGIO
AGIO
99 hedge funds and large institutions have $1.08B invested in Agios Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
34% more funds holding
Funds holding: 74 → 99 (+25)
61% less call options, than puts
Call options by funds: $569K | Put options by funds: $1.46M
Holders
99
Holding in Top 10
6
Calls
$569K
Puts
$1.46M
Top Buyers
| 1 | +$66.5M | |
| 2 | +$46.7M | |
| 3 | +$36.5M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$35M |
| 5 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$23.2M |
Top Sellers
| 1 | -$88.5M | |
| 2 | -$76.5M | |
| 3 | -$8.14M | |
| 4 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$3.92M |
| 5 |
Jennison Associates
New York
|
-$3.31M |